But with the anti-infective mAb development pipeline now representing one of the most active areas in mAb development 2, YUMAB is poised to join the race to develop next-generation mAbs to fight ...

Objective: To assess the effect of a short course of low-dose oral corticosteroid used as an adjunct to antimicrobials in patients with acute infective sinusitis. Study Design and Patients ...